mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |